Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selinexor + Irinotecan in Solid Tumors
NCT05177276Phase 2Withdrawn
- Start
- Sep 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in solid tumor. Planned start Sep 2014; status: withdrawn.
02
Drugs
selinexor
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05177276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05177276.